[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Notices]
[Pages 21887-21888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08269]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-617]
Importer of Controlled Substances Application: United States
Pharmacopeial Convention
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before May 20, 2020.
Such persons may also file a written request for a hearing on the
application on or before May 20, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 4, 2020, United States Pharmacopeial
Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, applied
to be registered as an importer of the following basic class(es) of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Methamphetamine.......................... 1105 II
Cathinone................................ 1235 I
Phenmetrazine............................ 1631 II
Methylphenidate.......................... 1724 II
Amobarbital.............................. 2125 II
Pentobarbital............................ 2270 II
Secobarbital............................. 2315 II
Glutethimide............................. 2550 II
Methaqualone............................. 2565 I
Lysergic acid diethylamide............... 7315 I
4-Methyl-2,5-dimethoxyamphetamine........ 7395 I
3,4-Methylenedioxyamphetamine............ 7400 I
4-Methoxyamphetamine..................... 7411 I
Phencyclidine............................ 7471 II
ANPP (4-Anilino-N-phenethyl-4-piperidine) 8333 II
Phenylacetone............................ 8501 II
Alphaprodine............................. 9010 II
Anileridine.............................. 9020 II
Cocaine.................................. 9041 II
Codeine-N-oxide.......................... 9053 I
[[Page 21888]]
Dihydrocodeine........................... 9120 II
Difenoxin................................ 9168 I
Diphenoxylate............................ 9170 II
Heroin................................... 9200 I
Levomethorphan........................... 9210 II
Levorphanol.............................. 9220 II
Meperidine............................... 9230 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine-N-oxide......................... 9307 I
Thebaine................................. 9333 II
Norlevorphanol........................... 9634 I
Oxymorphone.............................. 9652 II
Noroxymorphone........................... 9668 II
Alfentanil............................... 9737 II
Sufentanil............................... 9740 II
------------------------------------------------------------------------
The company plans to import the bulk control substances for
distribution of analytical reference standards to its customers for
analytical testing of raw materials.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08269 Filed 4-17-20; 8:45 am]
BILLING CODE 4410-09-P